Results 101 to 110 of about 196,277 (209)
Palliative treatment of malignant ascites: profile of catumaxomab
, 2010 Lila Ammouri, Eric E PrommerMayo Clinic Hospice and Palliative Medicine Program, Mayo Clinic College of Medicine, Mayo Clinic Hospital, Scottsdale, AZ, USAAbstract: Malignant ascites is the abnormal accumulation of fluid in the peritoneal cavity ...
Lila Ammouri, Eric E Prommer
core
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
, 2017 Aside from tumor cells, ovarian cancer-related ascites contains the immune components. The aim of this study was to evaluate whether a combination of clinical and immunological parameters can predict survival in patients with ovarian cancer.
Chen, Yu-Li;Chou, Cheng-Yang;Chang, Ming-Cheng;Lin, Han-Wei;Huang, Ching-Ting;Hsieh, Shu-Feng;Chen, Chi-An;Cheng, Wen-Fang +1 more
core +1 more source
Clinical Use of Auto-ascites Re-infusion After Purification
Huli yanjiu, 2001 Based on hemodialysis principles,purified auto-ascites re-infusion was carried out in 11 cases of chronic renal failure（CRF） complicated with severe ascites and blood purification were conducted simultaneously.Ascites of the patients was re-infused into ...
杨惠敏 +8 more
doaj
Antitumor and structure antioxidant activity relationship of Colchicine on Ehrlich ascites Carcinoma (EAC) in Female Mice [PDF]
, 2014 Colchicine has been reported to play important roles in hepatoprotection, anti-inflammation in vitro anti cancer activity. The present study was initiated to evaluate antioxidant and anti-cancer effects of colchicine (10µg/mice, i.p.) in mice after ...
Boshra, Sylvia A; Biochemistry Department, Faculty of Pharmacy, October 6 University, 6th October city, Egypt +1 more
core +2 more sources
, 2015 205 Background: Intractable ascites associated with cancerous ascites causes severe abdominal distention, loss of appetite, poor nutritional condition and reduce the quality of life.
Kanji Katayama +6 more
core +1 more source
Emerging treatment options for management of malignant ascites in patients with ovarian cancer
, 2012 Ramez N Eskander, Krishnansu S TewariDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California at Irvine, Irvine, CA, USAAbstract: Malignant ascites affects approximately 10% of patients with recurrent epithelial
Eskander RN, Tewari KS
core
Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascites
Hepatic Medicine: Evidence and Research, 2012 Anna Kohlhaas1, Esteban Durango1, Gunda Millonig1, Cecile Bastard2, Laurent Sandrin2, Mohammad Golriz3, Arianeb Mehrabi3, Markus W Büchler3, Helmut Karl Seitz1, Sebastian Mueller11Department of Medicine and Center for Alcohol Research, Liver ...
Mueller S +9 more
doaj
Pharmacological Treatment of Ascites: Challenges and Controversies
PharmaceuticalsAscites is the most common complication from cirrhosis related to portal hypertension and depicts the onset of hepatic decompensation. Ranging from uncomplicated to refractory ascites, the progression carries prognostic value by reflecting the ...
Jimmy Che-To Lai +5 more
doaj +1 more source
, 2012 The purpose of the present work was to evaluate anticarcinogenic and cytotoxic potential of Hemidesmus indicus methanolic root extract (HiRe) against Ehrlich Ascites Tumor.
Komal Kumar, J., Zarei, Mahsa
core